Vetting Celebrity Spokespersons to Ensure Return on Investment 
In this 2-minute audio snippet, Ambre Morley, Associate Director, Product Communications, Novo Nordisk, talks about vetting Paula Deen as a paid celebrity spokesperson for the Novo Victoza diabetes drug franchise and the importance of measuring celebrity return on investment (ROI).
Your browser does not support the audio element. Upgrade your browser to one that does
Meanwhile, listen to this Pharma Marketing Talk conversation with Morley about why her company teamed up with Paula Deen.
Aired LIVE on: Wednesday, January 18, 2012
Listen to internet radio with Pharmaguy on Blog Talk Radio
Pharmaguy Calls for Novo to Dump Deen (they did!)
